Last reviewed · How we verify

NCT06968689

Spatiotemporal Thalamocortical Alterations Underlie Experimental and Chronic Pain

Recruiting now NA Last updated 2 March 2026
What this trial tests

NA trial testing transcranial alternating current stimulation (tACS) in Pain in 60 participants. Currently enrolling.

Timeline
1 June 2025
Primary endpoint
31 December 2027
29 February 2028

Quick facts

Lead sponsorThe University of Texas Health Science Center, Houston
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingquadruple
Primary purposebasic science
Enrollment60
Start date1 June 2025
Primary completion31 December 2027
Estimated completion29 February 2028
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

The University of Texas Health Science Center, Houston

Who can join

Adults 18 to 60, any sex, with Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to assess thalamocortical (TC) connectivity during tonic pressure pain, to evaluate alpha activity during tonic pressure pain and to determine pressure pain ratings by using Electroencephalography (EEG), Functional Magnetic Resonance Imaging (fMRI), Transcranial Alternating Current Stimulation (tACS), sham and Transcranial random noise stimulation (tRNS)

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of transcranial alternating current stimulation (tACS)

Trials testing the same drug.

Other recruiting trials for Pain

Currently open trials in the same condition.

Other The University of Texas Health Science Center, Houston trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06968689.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing